Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02394379 · ClinicalTrials.gov registry record
Post Approval Study to Evaluate the Trulign™ Toric Posterior Chamber IOL
A clinical trial, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- 600
- Enrollment target
NCT02394379 is a clinical trial that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 600 participants.
The verdict
NCT02394379 has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- 600 participants
- Enrollment target
Study Summary
To evaluate the incidence of IOL vaulting (ie, position change) of the Trulign™ Toric IOL following cataract surgery.
Interventions
- DEVICE Trulign™ Toric IOL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2015-03-19 |
| Est. Completion | 2019-08-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02394379
The ClinicalTrials.gov registry entry for NCT02394379 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch & Lomb Incorporated, which has 174 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Trulign™ Toric IOL is the first listed.
NCT02394379 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02394379 about?
NCT02394379 is a clinical study titled "Post Approval Study to Evaluate the Trulign™ Toric Posterior Chamber IOL". To evaluate the incidence of IOL vaulting (ie, position change) of the Trulign™ Toric IOL following cataract surgery.
What is the current status of trial NCT02394379?
This trial is currently completed. The enrollment target is 600 participants. The study started on 2015-03-19. Estimated completion is 2019-08-05.
What interventions are being tested in trial NCT02394379?
The interventions under investigation include: Trulign™ Toric IOL (DEVICE).
Who is sponsoring clinical trial NCT02394379?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.